US · Healthcare

US Stem Cell Inc (USRM)

Biotechnology

US Stem Cell Inc (USRM) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for USRM

P/E ratio

18.00

US Stem Cell Inc (USRM) — FAQ

What is USRM's P/E ratio?

The price-to-earnings (P/E) ratio for US Stem Cell Inc (USRM) is 18.00 (data as of 2026-03-25).

Does US Stem Cell Inc pay a dividend?

Dividend yield is not available in the current snapshot for US Stem Cell Inc (USRM). Check the MyAverix Finance app for the latest dividend data.

What sector is US Stem Cell Inc in?

US Stem Cell Inc (USRM) is classified in the Healthcare sector (Biotechnology industry).

What exchange is USRM listed on?

USRM is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)